Paweł Przewięźlikowski
Allianz Polska OFE
BioNTech SE
TFI Allianz Polska S.A.
Nationale Nederlanden OFE
Bogusław Sieczkowski
Tadeusz Wesołowski (incl. Augebit FIZ)
Remaining Management Board and Supervisory Board Members
Remaining Shareholders
I agree with Ryvu Therapeutics Privacy Policy
By clicking "Subscribe”, I hereby consent to Ryvu Therapeutics S.A. sending me information on the company's activities, including the research conducted by it, to the e-mail address indicated by me. The controller of your personal data is Ryvu Therapeutics S.A., which manages the website www.ryvu.com.pl. (hereinafter: “Website”). We process your personal data in order to send you information about our activities and the research we conduct. You have the right to access your data, the right to request their rectification or erasure, the right to object, the right to restrict their processing and other rights described in detail in our Privacy Policy. Detailed information on the processing of your personal data: Link
